期刊文献+

石嘴山市学生HBsAg抗-HBs检测结果分析

Analysis of Test Results of HBsAg anti-HBs among Shizuishan Students
原文传递
导出
摘要 目的了解三年来中小学生中HBsAg携带率和保护性抗体抗-HBs的产生率的变化情况。方法采用酶联免疫吸附法(ELLSA)对本市中小学生进行HBsAg、体抗-HBs检测,并进行结果分析。结果我市中小学学生HBsAg总阳性率为1.74%,高中组高于初中组,初中高于小学组;抗-HBs阳性率小学组高于初中组,初中组高于高中组,且同年龄组中,随着年份的增加而增加。每年的HBsAg阳性率城市明显低于农村,每年的抗-HBs阳性率城市明显高于农村。结论我市学生HBsAg总阳性率为1.74%,低于全国平均水平9.09%,属于低感染地区;保护性抗体抗-HBs的阳性率逐年增加,城市高于农村。 Objective To understand the varying of HBsAg carrying rate and the generation rate of protective antibody - HBs among primary and secondary students since three years. Method To detect HBsAg and anti - HBs by using ELISA method and the results were analyzed in primary and secondary students of Shizuishan city. Results In our city, the masculinity rate of primary and secondary students was 1.74%. The rate of high school students was higher than the secondary students, and the sendondary students was higher than the primary students; The masculinity rate of anti - HBs in primary school was higher than secondary school, secondary school was higher than high school, Among the students of the same ages, the rate increased with the increase of the year. Every year, the masculinity rate of HBsAg in city was lower than in country, the masculinity of anti - HBswas higher than in country. Conclusions The masculinity rate of HBsAg that is lower 9. 09% than average of country is 1.74%, so our city belongs to low infection area; The masculinity rate of protective antibody in city is higher than in country, which increases with the increase of the year.
出处 《医学动物防制》 2010年第3期225-227,共3页 Journal of Medical Pest Control
关键词 HBSAG 检测 抗-HBS HbsAg Test Anti-HBs
  • 相关文献

参考文献2

二级参考文献34

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2邢玉兰 龚晓红 周绍莲.阻断围产期母婴传播最佳免疫方案的研究[J].中华实验和临床病毒学杂志,1990,4:485-488.
  • 3Strader DB,Wright T,Thomas DL,et al.Diagnosis,management,and treatment of hepatitis C.Hepatology,2004,39:1147-1171.
  • 4Seeger C,Mason WS.Hepatitis B virus biology.Microbiol Mol Biol Rev,2000,64:51-68.
  • 5Scaglioni PP,Melegari M,Wands JR.Biologic properities of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.Virology,1997,233:374-381.
  • 6Lai CL,Dienstag J,Schiff E,et al.Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.Clin Infect Dis,2003,36:687-696.
  • 7Hu KQ.Occult hepatitis B virus infection and its clinical implications.J Viral Hepat,2002,9:243-257.
  • 8Janssen HL,van Zonneveld M,Senturk H,et al.Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B:a randomised trial.Lancet,2005,365:123-129.
  • 9World Health Organization.Hepatitis B.World Health Organization Fact Sheet 204 dex.(Revised October 2000).WHO Web site.http://www.who.int/mediacentre/ factsheets/fs204/en/ in html.
  • 10de FranchisR,Hadengue A,Lau G,et al.EASL International Consensus Conference on Hepatitis B.J Hepatol,2003,39 Suppll:S3-S25.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部